FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Muzaffer Cicek

Research Profile

Physiology

Anatomy

Tumor Cell Line

Disorders

Chemicals & Drugs

Living Beings

Procedures

Gene Expression Profiling

Co-author Network

Publications

TOP 3
Steven Sizemore; Muzaffer Cicek; Nywana Sizemore; Kwok Peng Ng; Graham Casey
Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Ryuichi Fukuyama; Kwok Peng Ng; Muzaffer Cicek; Clare Kelleher; Roxana Niculaita; Graham Casey; Nywana Sizemore
Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
Rajeev S Samant; David W Clark; Rebecca A Fillmore; Muzaffer Cicek; Brandon J Metge; Kondethimmana H Chandramouli; Ann F Chambers; Graham Casey; Danny R Welch; Lalita A Shevde
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Muzaffer Cicek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Steven Sizemore; Muzaffer Cicek; Nywana Sizemore; Kwok Peng Ng; Graham Casey
Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin.
Cancer research 2007;67(13):6183-91.
2007: Ryuichi Fukuyama; Kwok Peng Ng; Muzaffer Cicek; Clare Kelleher; Roxana Niculaita; Graham Casey; Nywana Sizemore
Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
Molecular carcinogenesis 2007;46(5):402-13.
2007: Rajeev S Samant; David W Clark; Rebecca A Fillmore; Muzaffer Cicek; Brandon J Metge; Kondethimmana H Chandramouli; Ann F Chambers; Graham Casey; Danny R Welch; Lalita A Shevde
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
Molecular cancer 2007;6():6.
2006: David G Hicks; Brian J Yoder; Sarah Short; Shannon Tarr; Nichole L Prescott; Joseph P Crowe; Andrea E Dawson; G Thomas Budd; Steven Sizemore; Muzaffer Cicek; Toni K Choueiri; Raymond R Tubbs; Daniel P Gaile; Norma J Nowak; Mary Ann Accavitti-Loper; Andra R Frost; Danny R Welch; Graham Casey
Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6702-8.
2005: Minoru Horinaga; Ryuichi Fukuyama; Toru Nishiyama; Kelley M Harsch; Muzaffer Cicek; Warren D W Heston; Nywana Sizemore; Graham Casey; William Larchian
Novel enhanced lung-colonizing variant of murine MBT-2 bladder cancer cells.
Urology 2005;66(3):676-81.
2005: Muzaffer Cicek; Ryuichi Fukuyama; Danny R Welch; Nywana Sizemore; Graham Casey
Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cancer research 2005;65(9):3586-95.
2005: Anju Agarwal; Kingshuk Das; Natalia Lerner; Swati S Sathe; Muzaffer Cicek; Graham Casey; Nywana Sizemore
The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin.
Oncogene 2005;24(6):1021-31.
2004: Muzaffer Cicek; Rajeev S Samant; Michael Kinter; Danny R Welch; Graham Casey
Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.
Clinical & experimental metastasis 2004;21(2):149-57.